Related Experiment Video
Updated: Jul 24, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
Evaluation of pseudorabies virus as a gene transfer vector and an oncolytic agent for human tumor cells
Zsolt Boldogkoi1, Andras Bratincsak, Istvan Fodor
1Laboratory of Molecular Virology, Agricultural Biotechnology Center, Godollo, Hungary.
Background:
Psuedorabies virus (PrV) is a neurotropic herpesvirus with a wide host-range including several mammalian species, but the virus is non-pathogenic for humans. We have evaluated PrV as a gene delivery vector for human tumor cells.
Materials And Methods:
SK-N-SH (neuroblastoma), U-87MG (glioblastoma) and Hep-2 (hepatoma) cells were infected with five different mutant PrV strains carrying the lacZ or gfp reporter gene. Mouse and human colon tumors were treated with a ribonucleotide reductase null mutant PrV in a mouse model.
Results:
PrV penetrated the cells and expressed the reporter genes. The viruses could replicate and egress mature virions from the infected cells. The tested virus could infect and destroy both mouse and human tumors in vivo without signs of disease related to PrV infection.
Conclusion:
PrV can infect and spread in human cell culture and in tumor tissues. Thus, PrV might be considered as a potential gene delivery vector to human tumor cells, as well as an oncolytic agent for human tumors.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

